A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
for Colorectal Cancer
Sites in Fairfax +4 more locations
Sponsor: PAQ Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07300150·Phase 1·Recruiting·Listed Dec 2025
GI oncology Clinical Trials in Fairfax, VA
As of September 2026, 61 paid clinical trials are recruiting for GI oncology in Fairfax, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
61 clinical trials for GI oncology
·Clear filters· Email me when a new gi oncology trial opens in Fairfax, VA.
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for Head and Neck Squamous Cell Carcinoma HNSCC
Sites in Fairfax +8 more locations
Sponsor: Sutro Biopharma, Inc.
Sex: All·Age: 18+
Code: NCT07227168·Phase 1·Recruiting·Listed Nov 2025
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
for Colorectal Neoplasms
Sites in Fairfax +3 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07107230·Phase 1·Recruiting·Listed Aug 2025
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
for Non Small Cell Lung Cancer
Sites in Fairfax +4 more locations
Sponsor: Phanes Therapeutics
Sex: All·Age: 18+
Code: NCT05431270·Phase 1, Phase 2·Recruiting·Listed Jun 2022
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for Cervical Squamous Cell Carcinoma
Sites in Fairfax +8 more locations
Sponsor: Alentis Therapeutics AG
Sex: All·Age: 18+
Code: NCT07169734·Phase 1, Phase 2·Recruiting·Listed Sep 2025
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for Colorectal Cancer
Sites in Fairfax +8 more locations
Sponsor: Criterium, Inc.
Sex: All·Age: 18+
Code: NCT06992258·Phase 2·Recruiting·Listed May 2025
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
for Cancer
Sites in Fairfax +5 more locations
Sponsor: Angiex, Inc.
Sex: All·Age: 18+
Code: NCT06440005·Phase 1·Recruiting·Listed Jun 2024
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
for Adenoid Cystic Carcinoma
Sites in Fairfax +7 more locations
Sponsor: Rgenta Therapeutics Inc
Sex: All·Age: 18+
Code: NCT06462183·Phase 1·Recruiting·Listed Jun 2024
Pancreatic Cancer Early Detection Consortium
for Pancreas Cancer
Sites in Fairfax, Charlottesville +40 more locations
Sponsor: Arbor Research Collaborative for Health
Sex: All·Age: 18 - 90·Accepts healthy volunteers
Code: NCT04970056·Recruiting·Listed Jul 2021
The Vanguard Study: Testing a New Way to Screen for Cancer
for Bladder Carcinoma
Sites in Fairfax, Charlottesville +39 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 45 - 75·Accepts healthy volunteers
Code: NCT06995898·Recruiting·Listed May 2025
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
for Non-small Cell Lung Cancer
Sites in Fairfax +19 more locations
Sponsor: Institut de Recherches Internationales Servier
Sex: All·Age: 18+
Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
for Hepatocellular Carcinoma
Drug: Atezolizumab
Sites in Fairfax & Falls Church
Sponsor: Inova Health Care Services
Sex: All·Age: 18+
Code: NCT06789757·Phase 2·Recruiting·Listed Jan 2025
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
for Pancreatic Cancer
Sites in Fairfax +2 more locations
Sponsor: Proton Collaborative Group
Sex: All·Age: 18+
Code: NCT02598349·Phase 2·Recruiting·Listed Nov 2015
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
for Ovarian Cancer
Sites in Fairfax +1 more location
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Sex: All·Age: 18+
Code: NCT05746897·Phase 1·Recruiting·Listed Feb 2023
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
for Hepatocellular Carcinoma
Sites in Fairfax & Falls Church
Sponsor: Inova Health Care Services
Sex: All·Age: 18+
Code: NCT06007846·Phase 2, Phase 3·Recruiting·Listed Aug 2023
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in Fairfax, Fort Belvoir +70 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
for Esophageal Squamous Cell Carcinoma
Sites in Fairfax +9 more locations
Sponsor: Plexium, Inc.
Sex: All·Age: 18+
Code: NCT07284186·Phase 1·Recruiting·Listed Dec 2025
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
for HNSCC
Sites in Fairfax +17 more locations
Sponsor: Normunity AccelCo, Inc.
Sex: All·Age: 18+
Code: NCT07182149·Phase 1·Recruiting·Listed Sep 2025
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for Biliary Tract Cancer
Drug: Rilvegostomig
Sites in Fairfax +30 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 99
Code: NCT06467357·Phase 3·Recruiting·Listed Jun 2024
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for HER2-positive Gastric Cancer
Drug: Rilvegostomig
Sites in Fairfax, Charlottesville +43 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
for Triple Negative Breast Cancer
Sites in Fairfax +9 more locations
Sponsor: Dren Bio
Sex: All·Age: 18+
Code: NCT06999187·Phase 1·Recruiting·Listed May 2025